Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Rylo Health
CoreAge Rx and Rylo Health both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxRylo Health
Ranked #143 · Grade C
Best for: A mother comparing an annual outlay who wants the dose ladder not to move the number.
Visit Rylo HealthThe verdict
CoreAge Rx edges out Rylo Health on the Rx-Readiness Score, 95 to 59 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Rylo Health is still a genuine option — cost it both ways and the decision is small and clear. Twelve months of semaglutide is $1,668 monthly against $1,196 on the quarterly plan — $472 apart. Tirzepatide is $2,748 against $1,916, so $832. The seller leads with the quarterly-derived figure, as several here do, but it prints the monthly one on the same line and says under the block that the headline is a quarterly rate. Then it shows the flat price across three ascending doses. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Rylo Health |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 59/100 · C |
| Overall rank | #1 | #143 |
| Semaglutide | $99/mo | $139/mo month to month |
| Tirzepatide | $149/mo | $229/mo month to month |
| Coverage | All 50 states | Not published; described only as licensed US providers |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Rylo Health
Ranked #143 · Grade C
What we like
- The month-to-month price sits on the same line as the quarterly one, so both totals can be computed at a glance
- States that the headline reflects a quarterly rate billed every three months
- Flat at every dose, shown as 2.5 mg, 5.0 mg and 7.5 mg all at $229
The caveats
- The lead figure is the quarterly-derived one, so a skim gives $99.67 rather than $139
- NAD+, sermorelin and glutathione carry prices in the same grid in the same format
- No compounding pharmacy named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Rylo Health against other providers on our shortlist.
Or browse the full comparison hub.